What are the consequences of DVT?

After a blood clot starts to form, another series of reactions almost immediately begins to dissolve (lyse) the clot. The purpose of this process is to confine the clot to the injured area of the blood vessel, limit the size of the clot, and prevent it from growing too large. Sometimes DVT can be completely dissolved or lysed by the body’s own natural processes. Even under these circumstances, however, the clot is likely to cause permanent damage to the vein and its valves. In fact, 5 to 30 percent of individuals who experience DVT develop a second or recurrent DVT within five years of the first episode.

Sometimes, a clot serves as a surface on which another clot forms, so that the clot continues to grow. As it increases in size, blood flow may be completely blocked within a vein. The clot may even extend into the larger vein to which the present vein is connected. In this case, circulation to a leg, arm, or other organ may be so impaired that the limb, organ, or person’s life may be threatened.

In one of every five cases, the clot (or a piece of it) breaks free and travels through progressively larger veins, through the vena cava, and through the right side of the heart, and then wedges into one of the pulmonary arteries or its branches, resulting in pulmonary embolism (PE).  As many as 600,000 Americans are hospitalized each year for DVT and its primary complication, PE. In the United States, DVT and PE account for as many as 300,000 deaths per year.

Three to four percent of all patients who experience PE suffer from chronic (persistent) obstruction of blood flow through the lungs—a condition known as

Chronic thromboembolic pulmonary hypertension (CTEPH)

High blood pressure in the lungs that occurs in a small percentage of patients who have had pulmonary embolism. The most common symptom is shortness of breath. This problem usually progresses but may be cured with surgery.

chronic thromboembolic pulmonary hypertension (CTEPH).  The obstruction of this blood flow increases the blood pressure in the pulmonary arteries, which carry blood from the right side of the heart to the lungs. CTEPH therefore strains the right side of the heart, causing symptoms of heart failure including shortness of breath. (See Questions 80 and 81.)

Current News

NBCA Launches Season 2 of Taking a Breath: A Stop the Clot Podcast

The National Blood Clot Alliance (NBCA) is thrilled to launch Season Two of Taking a Breath: A Stop the Clot…

Dr. Suman Wasan Joins NBCA’s Medical and Scientific Advisory Board

The National Blood Clot Alliance is thrilled to welcome Dr. Suman Wasan to our Medical and Scientific Advisory Board. Dr.…